[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606612":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":29,"responsibleParty":46,"collaborators":11,"id":49,"slug":11,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":11,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":11,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":11,"overallStatus":31,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"VGAIT","EXPERIMENTAL",null,[13],"Other: Video-Guided Acupuncture Imagery Treatment (VGAIT)",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Video-Guided Acupuncture Imagery Treatment (VGAIT)","Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Sierra Hodges","CONTACT","6177265004","sahodges@mgb.org",{"name":26,"role":22,"phone":27,"phoneExt":11,"email":28},"Jian Kong","16179620978","jkong2@mgh.harvard.edu",[30],{"facility":5,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Charlestown","Massachusetts","02129","United States",{"type":37,"coordinates":38},"Point",[39,40],-71.062,42.37787,{"lat":40,"lon":39},[43],{"name":44,"role":22,"phone":45,"phoneExt":11,"email":24},"Sierra Hodges, B.S.","617-726-5004",{"type":47,"investigatorFullName":26,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Professor","100606612",false,"NCT07177820","VGAIT for Chemotherapy-induced Peripheral Neuropathy","Video-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy","Inclusion Criteria:\n\n* at least 18 years of age\n* have histologically confirmed stage I-III breast cancer,\n* have completed adjuvant taxane-based chemotherapy (alone or in combination), ,\n* have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.\n\nExclusion Criteria:\n\n* concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),\n* having metastatic or recurrent disease,\n* history of preexisting peripheral neuropathy prior to chemotherapy,\n* uncontrolled seizure disorder,\n* unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.","FEMALE","18 Years","80 Years",{"count":59,"type":60},20,"ESTIMATED","INTERVENTIONAL",[63],"NA","Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)",[66],"Chemotherapy-induced Peripheral Neuropathy","2026-02-06",{"date":69,"type":70},"2026-02-10","ACTUAL",{"date":72,"type":70},"2026-01-06",{"date":74,"type":60},"2026-12-31",{"name":5,"class":6},1]